BioOutsource is a leading provider of contract testing services to the global biopharmaceutical and biotechnology industry.
Our core offering includes a comprehensive suite of services to support the testing of biologic drugs and vaccines. In particular, BioOutsource specialise in the characterisation and comparability of biosimilar monoclonal antibodies.
Our scientists possess unrivalled scientific and regulatory expertise to help solve the complex challenges encountered during the development of biologic drugs and vaccines.
Our unique offering helps assess the quality and safety of biologics, advancing drug candidates through each phase of the drug development pathway:
- Commitment to Excellent Customer Service – Dedicated client support
- Innovation – Industry leading R&D
- Assay Availability – Most comprehensive range of off-the-shelf assays
Our experts and client managers work closely with clients, adding value to the process through scientific insights and regular communication and updates.
Doubles the Company’s Capacity for Biologics Contract Testing and Biosimilar Characterisation in Response to Surging Demand, and Creates 50 New Jobs Glasgow, Scotland, July 27, 2015 – BioOutsource Ltd. (“BioOutsource”), part of Sartorius Stedim Biotech Group and a global leader in biologics contract testing and biosimilar characterisation for the biopharmaceutical industry, today announced the opening More
Takeover expands SSB’s service portfolio Glasgow, April 17, 2015 – BioOutsource Ltd. (BioOutsource), a leading provider of contract testing services for the biopharmaceutical industry, has been acquired by Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries. BioOutsource provides contract testing services to Global biopharmaceutical clients in order to monitor the safety More
Free Webinar to Explore Comparability Challenges Faced by Developers of Biosimilars GLASGOW, Scotland and CAMBRIDGE, Mass. – 9 February 2015 – BioOutsource Ltd. (“BioOutsource”), a global leader in biologics contract testing and biosimilar characterization for the biopharmaceutical industry, today announced that it will be hosting a free webinar on Thursday, 12 February, at 3:00 p.m. More